APA (7th ed.) Citation

O'Brien, S., Furman, R. R., Coutre, S., Flinn, I. W., Burger, J. A., Blum, K., . . . Byrd, J. C. (2018). Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: A 5-year experience. Blood, 131(17), 1910-1919. https://doi.org/10.1182/blood-2017-10-810044

Chicago Style (17th ed.) Citation

O'Brien, Susan, et al. "Single-agent Ibrutinib in Treatment-naïve and Relapsed/refractory Chronic Lymphocytic Leukemia: A 5-year Experience." Blood 131, no. 17 (2018): 1910-1919. https://doi.org/10.1182/blood-2017-10-810044.

MLA (9th ed.) Citation

O'Brien, Susan, et al. "Single-agent Ibrutinib in Treatment-naïve and Relapsed/refractory Chronic Lymphocytic Leukemia: A 5-year Experience." Blood, vol. 131, no. 17, 2018, pp. 1910-1919, https://doi.org/10.1182/blood-2017-10-810044.